Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Coronary Heart Disease Diagnostic Imaging Devices Market, by Modality
1.4.2 North America Coronary Heart Disease Diagnostic Imaging Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Mar – 2022, Feb) Leading Players
Chapter 4. North America Coronary Heart Disease Diagnostic Imaging Devices Market by Modality
4.1 North America Nuclear Medicine Market by Country
4.2 North America Computed Tomography Market by Country
4.3 North America Ultrasound Market by Country
4.4 North America X rays Market by Country
4.5 North America Magnetic Resonance Imaging Market by Country
Chapter 5. North America Coronary Heart Disease Diagnostic Imaging Devices Market by Country
5.1 US Coronary Heart Disease Diagnostic Imaging Devices Market
5.1.1 US Coronary Heart Disease Diagnostic Imaging Devices Market by Modality
5.2 Canada Coronary Heart Disease Diagnostic Imaging Devices Market
5.2.1 Canada Coronary Heart Disease Diagnostic Imaging Devices Market by Modality
5.3 Mexico Coronary Heart Disease Diagnostic Imaging Devices Market
5.3.1 Mexico Coronary Heart Disease Diagnostic Imaging Devices Market by Modality
5.4 Rest of North America Coronary Heart Disease Diagnostic Imaging Devices Market
5.4.1 Rest of North America Coronary Heart Disease Diagnostic Imaging Devices Market by Modality
Chapter 6. Company Profiles
6.1 General Electric (GE) Co. (GE Healthcare)
6.1.1 Company Overview
6.1.1 Financial Analysis
6.1.2 Segmental and Regional Analysis
6.1.3 Research & Development Expense
6.1.4 Recent Strategies and Developments:
6.1.4.1 Partnerships, Collaborations and Agreements:
6.1.4.2 Approvals and Trials:
6.1.5 SWOT Analysis
6.2 Koninklijke Philips N.V.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent Strategies and Developments:
6.2.5.1 Partnerships, Collaborations and Agreements:
6.2.5.2 Acquisitions and Mergers:
6.3 Siemens Healthineers AG (Siemens AG)
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent Strategies and Developments:
6.3.5.1 Product Launches and Product Expansions:
6.4 Fujifilm Holdings Corporation
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent Strategies and Developments:
6.4.5.1 Product Launches and Product Expansions:
6.5 Canon, Inc. (Canon Medical Systems Corporation)
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.5 Recent strategies and developments:
6.5.5.1 Partnerships, Collaborations, and Agreements:
6.5.5.2 Product Launches and Product Expansions:
6.6 Mindray Medical International Limited
6.6.1 Company Overview
6.6.2 Recent strategies and developments:
6.6.2.1 Product Launches and Product Expansions:
6.7 Chison Medical Technologies Co., Ltd.
6.7.1 Company Overview
6.8 Analogic Corporation (Altaris Capital Partners)
6.8.1 Company Overview
Unique Offerings 